Compare Amgen, Inc. (AMGN) vs Reddit Inc (RDDT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amgen, Inc. vs Reddit Inc — how do they compare? Amgen, Inc. trades at $363.66 (market cap $196.12B), while Reddit Inc trades at $195 (market cap $37.60B). The key difference: Amgen, Inc. is far larger — about 5.2× Reddit Inc's market cap, and Amgen, Inc. pays a 2.77% dividend while Reddit Inc pays none. Which is the better fit depends on your goals.
| AMGN | RDDT | |
|---|---|---|
Market Cap | $196.12B | $37.60B |
Sector | Health | Media |
52-Week High | $388.16 | $270.71 |
52-Week Low | $271.18 | $121.84 |
Enterprise Value | $241.41B | $34.86B |
Dividend Yield | 2.77% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
Reddit (RDDT) trades at $195.42, down 2.58% amid recent profit-taking but maintains strong fundamentals with 45% revenue growth and expanding profitability. The stock shows bullish technical signals with support at $193 and resistance at $204, while analyst consensus remains strongly positive with a $229.11 price target. Recent news highlights digital advertising momentum and AI safety initiatives as key growth drivers.
Outlook remains favorable with accelerating digital ad spending and strong execution, though elevated valuation metrics and competitive pressures present risks. The upcoming Q2 2026 earnings report on July 30 will be crucial for validating growth trajectory and maintaining investor confidence in the company's expansion story.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →
